Adinda Wens
Universitätsmedizin Göttingen
Institut für Neuroimmunologie und Multiple
Sklerose Forschung
Von-Siebold-Str. 3 a, 37075 Göttingen
Tel: +49-(0)-551-39-61160
E-mail: adinda.wens@med.uni-goettingen.de
View secondary antibody
Basic data
| PID | secondary-0105 |
| EPIC PID | secondary-0105 |
| Research group | RG Gärtner |
| Quality (mean) | no score (0.00) |
| Sharing level | Public |
Antibody data
| Antibody Registry ID(s) | AB_2313567 |
| Name | Peroxidase-AffiniPure Goat Anti-Rabbit IgG (H+L) antibody |
| Alternative name | |
| Lab ID | |
| Tag / Fluorophore | Horseradish Peroxidase |
| Raised in | Goat |
| Clone | |
| Isotype | |
| Clonality | |
| Antigen | IgG (H+L) |
| Excitation Max. | |
| Emission Max. | |
| Crafted By | company |
| Company / Manufacturer | Jackson ImmunoResearch |
| Catalog no. | 111-035-003 |
| Lot no. | |
| Description | 1:500 - 1:5,000 for immunohisto/cytochemistry 1:5,000 - 1:100,000 for ELISA and Western blotting with chromogenic substrates 1:10,000 - 1:200,000 for Western blotting with ECL substrates |
| Localization | |
| Storage instruction | Storage and Rehydration: Store freeze-dried solid at 2-8°C. Rehydrate with the indicated volume of dH2O and centrifuge if not clear. Prepare working dilution on day of use. Product is stable for about 6 weeks at 2-8°C as an undiluted liquid. Extended Storage after Rehydration: Aliquot and freeze at -70°C or below. Avoid repeated freezing and thawing. Alternatively, add an equal volume of glycerol (ACS grade or better) for a final concentration of 50%, and store at -20°C as a liquid. |
| Receipt date | 2023-06-09 00:00:00 |
| Preparation date | 2023-06-09 00:00:00 |
| Created by | , |
| Last modified | , |
External links
| Antibodypedia | - |
| HGNC | - |
| Wikipedia | - |
| Uniprot | - |
| GeneCards | - |
| Antibody Registry | http://antibodyregistry.org/search?q=AB_2313567 |
Applications
No application comments yet.
Linked publications
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
Schlotawa L, Tyka K, Kettwig M, Ahrens‐Nicklas RC, Baud M, Berulava T, Brunetti‐Pierri N, Gagne A, Herbst ZM, Maguire JA, Monfregula J, Pena T, Radhakrishnan K, Schröder S, Waxman EA, Ballabio A, Dierks T, Fischer A, French DL, Gelb MH, Gärtner J
EMBO Mol Med 2023 : 10.15252/emmm.202114837
